News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
(USGovernment-News.Com, September 11, 2015 ) Bard IVC Filter Lawsuits Information: An NBC News investigation questioned whether C.R. Bard Inc., told all that it knew about its Recovery IVC filter’s potential flaw of fracturing after it is implanted in patients to capture blood clots. NBC News investigators examined government data and found at least 27 deaths were associated with the Recovery IVC filter and 300 non-fatal reports were made regarding the medical device. After receiving complaints about the Recovery filter, Bard hired a doctor to do a “confidential study,” which NBC News obtained. The doctor found the Recovery filter had “higher rates of relative risk for death, filter fracture and movement than all its competitors.”
One woman told NBC News that she had a Recovery implant and developed a severe headache four months later and passed out. Tests showed that a piece of the filter had broken and pierced her heart. Dodi Froehlich, 45, said she had to have emergency open heart surgery to remove the broken piece of filter. Kevin Keech said his 55-year-old mother, Gloria Adams, had a Recovery filter implanted after having a brain aneurysm in 2004. She died one week later. An autopsy revealed that the filter failed to catch a blood clot which pushed “the entire device into her heart” and punctured it. Bard sold more than 34,000 Recovery filters before replacing them with its G2 IVC filter, according to NBC news investigators.
“The NBC News investigation reflects identical points that plaintiffs make in their lawsuits against C.R. Bard, that the company was aware of the dangers of its Recovery IVC filter but failed to warn the public about the potential dangers associated with the device,” says Alonso Krangle LLP, which is representing a plaintiff in a Bard G2 IVC filter lawsuit case. (Case No. 2:13-cv-02281, U.S. District Court, Eastern District of New York)
According to the U.S. Food and Drug Administration (FDA), retrievable inferior vena cava (IVC) filters are small wire devices inserted in the inferior vena cava (a main vessel returning blood from the lower half of the body to the heart). IVC filters are designed to catch blood clots that may break free from lower parts of the body and travel toward the lungs and cause a pulmonary embolism (a blood clot in the lungs). IVC filters are used by patients at risk of a pulmonary embolism but cannot take anticoagulants or have taken blood thinners in the past but they failed to help them.
[fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm221676.htm, August 9, 2010]
The Bard Recovery IVC filter was approved by the U.S. Food and Drug Administration (FDA) in 2002, according to Bard IVC filter lawsuits. After receiving such complaints as the device migrating and fracturing, the company took the product off the market in 2005 and replaced it with the G2 IVC filter, which Bard said would provide “enhanced fracture resistance,” “improved centering” and “increased migration resistance.” (In Re: Bard IVC Filters Product Liability Litigation – MDL No. 2641)
Court documents indicate that 22 lawsuits filed in federal courts nationwide against C.R. Bard Inc. and Bard Peripheral Vascular, Inc., were transferred on August 17 and consolidated in the U.S. District Court, District of Arizona. The U.S. Judicial Panel on Multidistrict Litigation said in its transfer order that it is centralizing the cases because they had common factual questions arising from allegations that defects in the design of Bard’s retrievable inferior vena cava filters (“IVC filters”) make them more likely to fracture, migrate, tilt, or perforate the inferior vena cava and cause injury. (In Re: Bard IVC Filters Product Liability Litigation – MDL No. 2641)
Among the federal complaints is one filed by Alonso Krangle on behalf of a New York woman who underwent a Bard G2 filter implant in May 2009. According to the lawsuit, the filter’s components broke inside of her and she suffered serious injuries and damage to her internal organs as a result of the G2 filter’s failure. (Case No. 2:13-cv-02281, U.S. District Court, Eastern District of New York) (In Re: Bard IVC Filters Product Liability Litigation – MDL No. 2641)
About Alonso Krangle LLP And Filing A Bard IVC Filter Lawsuit
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on handling significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and New Jersey. For more information about Alonso Krangle and filing a Bard IVC Filter Lawsuit, please contact us at 1-800-403-6191 or visit our website, fightforvictims.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:
